nodes	percent_of_prediction	percent_of_DWPC	metapath
Estriol—SLCO1A2—Methotrexate—lymphatic system cancer	0.195	0.423	CbGbCtD
Estriol—ABCB1—Mitoxantrone—lymphatic system cancer	0.126	0.274	CbGbCtD
Estriol—ABCB1—Vincristine—lymphatic system cancer	0.087	0.189	CbGbCtD
Estriol—ABCB1—Methotrexate—lymphatic system cancer	0.0527	0.114	CbGbCtD
Estriol—Deep vein thrombosis—Fludarabine—lymphatic system cancer	0.0132	0.0245	CcSEcCtD
Estriol—Cholelithiasis—Fludarabine—lymphatic system cancer	0.0129	0.024	CcSEcCtD
Estriol—Seborrhoeic dermatitis—Fludarabine—lymphatic system cancer	0.0118	0.0219	CcSEcCtD
Estriol—Thrombophlebitis—Mechlorethamine—lymphatic system cancer	0.0104	0.0193	CcSEcCtD
Estriol—Cerebral haemorrhage—Carmustine—lymphatic system cancer	0.0093	0.0173	CcSEcCtD
Estriol—Cerebral haemorrhage—Vincristine—lymphatic system cancer	0.00888	0.0165	CcSEcCtD
Estriol—Neoplasm—Teniposide—lymphatic system cancer	0.00828	0.0154	CcSEcCtD
Estriol—Cyst—Carmustine—lymphatic system cancer	0.00771	0.0143	CcSEcCtD
Estriol—Depression—Mechlorethamine—lymphatic system cancer	0.00693	0.0129	CcSEcCtD
Estriol—Tenderness—Bleomycin—lymphatic system cancer	0.00676	0.0125	CcSEcCtD
Estriol—Menorrhagia—Vincristine—lymphatic system cancer	0.00664	0.0123	CcSEcCtD
Estriol—Menorrhagia—Mitoxantrone—lymphatic system cancer	0.00647	0.012	CcSEcCtD
Estriol—Cardiac failure congestive—Fludarabine—lymphatic system cancer	0.00644	0.0119	CcSEcCtD
Estriol—Visual disturbance—Fludarabine—lymphatic system cancer	0.00616	0.0114	CcSEcCtD
Estriol—Cerebrovascular accident—Fludarabine—lymphatic system cancer	0.00596	0.0111	CcSEcCtD
Estriol—Erythema multiforme—Mechlorethamine—lymphatic system cancer	0.0059	0.0109	CcSEcCtD
Estriol—Dementia—Methotrexate—lymphatic system cancer	0.00582	0.0108	CcSEcCtD
Estriol—Alopecia—Mechlorethamine—lymphatic system cancer	0.00551	0.0102	CcSEcCtD
Estriol—Pulmonary embolism—Carmustine—lymphatic system cancer	0.00515	0.00955	CcSEcCtD
Estriol—Neoplasm—Carmustine—lymphatic system cancer	0.00466	0.00864	CcSEcCtD
Estriol—Unspecified disorder of skin and subcutaneous tissue—Mechlorethamine—lymphatic system cancer	0.00459	0.00852	CcSEcCtD
Estriol—Abnormal vision—Carmustine—lymphatic system cancer	0.00449	0.00833	CcSEcCtD
Estriol—Acute coronary syndrome—Fludarabine—lymphatic system cancer	0.00444	0.00823	CcSEcCtD
Estriol—Anaphylactic shock—Mechlorethamine—lymphatic system cancer	0.00443	0.00822	CcSEcCtD
Estriol—Myocardial infarction—Fludarabine—lymphatic system cancer	0.00441	0.00819	CcSEcCtD
Estriol—Infection—Mechlorethamine—lymphatic system cancer	0.0044	0.00817	CcSEcCtD
Estriol—Cerebrovascular accident—Bleomycin—lymphatic system cancer	0.00437	0.00811	CcSEcCtD
Estriol—Thrombophlebitis—Carmustine—lymphatic system cancer	0.00432	0.00801	CcSEcCtD
Estriol—Skin disorder—Mechlorethamine—lymphatic system cancer	0.0043	0.00798	CcSEcCtD
Estriol—Alopecia—Teniposide—lymphatic system cancer	0.00406	0.00754	CcSEcCtD
Estriol—Deep vein thrombosis—Methotrexate—lymphatic system cancer	0.00392	0.00727	CcSEcCtD
Estriol—Polyp—Methotrexate—lymphatic system cancer	0.00392	0.00727	CcSEcCtD
Estriol—Visual impairment—Fludarabine—lymphatic system cancer	0.00389	0.00722	CcSEcCtD
Estriol—Cardiac failure congestive—Mitoxantrone—lymphatic system cancer	0.00383	0.00711	CcSEcCtD
Estriol—Erythema multiforme—Fludarabine—lymphatic system cancer	0.00382	0.00709	CcSEcCtD
Estriol—Alopecia—Fludarabine—lymphatic system cancer	0.00357	0.00662	CcSEcCtD
Estriol—Cyst—Methotrexate—lymphatic system cancer	0.00357	0.00662	CcSEcCtD
Estriol—Malnutrition—Fludarabine—lymphatic system cancer	0.00352	0.00653	CcSEcCtD
Estriol—Hypertension—Teniposide—lymphatic system cancer	0.00346	0.00641	CcSEcCtD
Estriol—Weight decreased—Bleomycin—lymphatic system cancer	0.00335	0.00621	CcSEcCtD
Estriol—Oedema—Teniposide—lymphatic system cancer	0.00327	0.00606	CcSEcCtD
Estriol—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.00326	0.00606	CcSEcCtD
Estriol—Acute coronary syndrome—Bleomycin—lymphatic system cancer	0.00325	0.00604	CcSEcCtD
Estriol—Infection—Teniposide—lymphatic system cancer	0.00325	0.00602	CcSEcCtD
Estriol—Myocardial infarction—Bleomycin—lymphatic system cancer	0.00324	0.006	CcSEcCtD
Estriol—Pruritus—Mechlorethamine—lymphatic system cancer	0.00314	0.00582	CcSEcCtD
Estriol—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00303	0.00562	CcSEcCtD
Estriol—Depression—Carmustine—lymphatic system cancer	0.00287	0.00533	CcSEcCtD
Estriol—Anaphylactic shock—Fludarabine—lymphatic system cancer	0.00287	0.00533	CcSEcCtD
Estriol—Oedema—Fludarabine—lymphatic system cancer	0.00287	0.00533	CcSEcCtD
Estriol—Infection—Fludarabine—lymphatic system cancer	0.00285	0.00529	CcSEcCtD
Estriol—Vomiting—Mechlorethamine—lymphatic system cancer	0.00282	0.00523	CcSEcCtD
Estriol—Nervous system disorder—Fludarabine—lymphatic system cancer	0.00282	0.00522	CcSEcCtD
Estriol—Rash—Mechlorethamine—lymphatic system cancer	0.00279	0.00518	CcSEcCtD
Estriol—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00279	0.00518	CcSEcCtD
Estriol—Weight decreased—Vincristine—lymphatic system cancer	0.00279	0.00518	CcSEcCtD
Estriol—Depression—Vincristine—lymphatic system cancer	0.00274	0.00509	CcSEcCtD
Estriol—Weight increased—Mitoxantrone—lymphatic system cancer	0.00273	0.00507	CcSEcCtD
Estriol—Weight decreased—Mitoxantrone—lymphatic system cancer	0.00272	0.00504	CcSEcCtD
Estriol—Acute coronary syndrome—Vincristine—lymphatic system cancer	0.00271	0.00503	CcSEcCtD
Estriol—Myocardial infarction—Vincristine—lymphatic system cancer	0.0027	0.005	CcSEcCtD
Estriol—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.00267	0.00496	CcSEcCtD
Estriol—Bone disorder—Methotrexate—lymphatic system cancer	0.00264	0.0049	CcSEcCtD
Estriol—Acute coronary syndrome—Mitoxantrone—lymphatic system cancer	0.00264	0.0049	CcSEcCtD
Estriol—Nausea—Mechlorethamine—lymphatic system cancer	0.00263	0.00488	CcSEcCtD
Estriol—Myocardial infarction—Mitoxantrone—lymphatic system cancer	0.00263	0.00487	CcSEcCtD
Estriol—Alopecia—Bleomycin—lymphatic system cancer	0.00262	0.00486	CcSEcCtD
Estriol—Urticaria—Teniposide—lymphatic system cancer	0.0026	0.00481	CcSEcCtD
Estriol—Abdominal pain—Teniposide—lymphatic system cancer	0.00258	0.00479	CcSEcCtD
Estriol—Oedema peripheral—Carmustine—lymphatic system cancer	0.00255	0.00473	CcSEcCtD
Estriol—Connective tissue disorder—Carmustine—lymphatic system cancer	0.00254	0.00471	CcSEcCtD
Estriol—Dyspepsia—Fludarabine—lymphatic system cancer	0.00253	0.00469	CcSEcCtD
Estriol—Visual impairment—Carmustine—lymphatic system cancer	0.00249	0.00462	CcSEcCtD
Estriol—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.00248	0.0046	CcSEcCtD
Estriol—Pain—Fludarabine—lymphatic system cancer	0.00246	0.00455	CcSEcCtD
Estriol—Connective tissue disorder—Vincristine—lymphatic system cancer	0.00243	0.0045	CcSEcCtD
Estriol—Eye disorder—Carmustine—lymphatic system cancer	0.00242	0.00448	CcSEcCtD
Estriol—Hypersensitivity—Teniposide—lymphatic system cancer	0.00241	0.00446	CcSEcCtD
Estriol—Vaginal inflammation—Methotrexate—lymphatic system cancer	0.00239	0.00443	CcSEcCtD
Estriol—Pulmonary embolism—Methotrexate—lymphatic system cancer	0.00239	0.00443	CcSEcCtD
Estriol—Pruritus—Teniposide—lymphatic system cancer	0.00231	0.00429	CcSEcCtD
Estriol—Cardiac disorder—Vincristine—lymphatic system cancer	0.00229	0.00425	CcSEcCtD
Estriol—Alopecia—Carmustine—lymphatic system cancer	0.00229	0.00424	CcSEcCtD
Estriol—Mental disorder—Carmustine—lymphatic system cancer	0.00227	0.0042	CcSEcCtD
Estriol—Vaginal infection—Methotrexate—lymphatic system cancer	0.00225	0.00418	CcSEcCtD
Estriol—Malnutrition—Carmustine—lymphatic system cancer	0.00225	0.00418	CcSEcCtD
Estriol—Angiopathy—Vincristine—lymphatic system cancer	0.00224	0.00416	CcSEcCtD
Estriol—Diarrhoea—Teniposide—lymphatic system cancer	0.00224	0.00415	CcSEcCtD
Estriol—Alopecia—Vincristine—lymphatic system cancer	0.00218	0.00405	CcSEcCtD
Estriol—Back pain—Carmustine—lymphatic system cancer	0.00218	0.00404	CcSEcCtD
Estriol—Mental disorder—Vincristine—lymphatic system cancer	0.00216	0.00401	CcSEcCtD
Estriol—Neoplasm—Methotrexate—lymphatic system cancer	0.00216	0.004	CcSEcCtD
Estriol—Alopecia—Mitoxantrone—lymphatic system cancer	0.00212	0.00394	CcSEcCtD
Estriol—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00212	0.00392	CcSEcCtD
Estriol—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.00211	0.0039	CcSEcCtD
Estriol—Oedema—Bleomycin—lymphatic system cancer	0.00211	0.0039	CcSEcCtD
Estriol—Infection—Bleomycin—lymphatic system cancer	0.00209	0.00388	CcSEcCtD
Estriol—Back pain—Vincristine—lymphatic system cancer	0.00208	0.00386	CcSEcCtD
Estriol—Vomiting—Teniposide—lymphatic system cancer	0.00208	0.00385	CcSEcCtD
Estriol—Rash—Teniposide—lymphatic system cancer	0.00206	0.00382	CcSEcCtD
Estriol—Dermatitis—Teniposide—lymphatic system cancer	0.00206	0.00382	CcSEcCtD
Estriol—Headache—Teniposide—lymphatic system cancer	0.00205	0.0038	CcSEcCtD
Estriol—Pruritus—Fludarabine—lymphatic system cancer	0.00203	0.00377	CcSEcCtD
Estriol—Back pain—Mitoxantrone—lymphatic system cancer	0.00202	0.00376	CcSEcCtD
Estriol—Thrombophlebitis—Methotrexate—lymphatic system cancer	0.002	0.00371	CcSEcCtD
Estriol—Diarrhoea—Fludarabine—lymphatic system cancer	0.00196	0.00364	CcSEcCtD
Estriol—Hypertension—Carmustine—lymphatic system cancer	0.00194	0.00361	CcSEcCtD
Estriol—Nausea—Teniposide—lymphatic system cancer	0.00194	0.0036	CcSEcCtD
Estriol—Anxiety—Carmustine—lymphatic system cancer	0.00191	0.00354	CcSEcCtD
Estriol—Hypertension—Vincristine—lymphatic system cancer	0.00186	0.00344	CcSEcCtD
Estriol—Oedema—Carmustine—lymphatic system cancer	0.00184	0.00341	CcSEcCtD
Estriol—Visual disturbance—Methotrexate—lymphatic system cancer	0.00183	0.00339	CcSEcCtD
Estriol—Infection—Carmustine—lymphatic system cancer	0.00183	0.00339	CcSEcCtD
Estriol—Vomiting—Fludarabine—lymphatic system cancer	0.00183	0.00339	CcSEcCtD
Estriol—Rash—Fludarabine—lymphatic system cancer	0.00181	0.00336	CcSEcCtD
Estriol—Dermatitis—Fludarabine—lymphatic system cancer	0.00181	0.00335	CcSEcCtD
Estriol—Hypertension—Mitoxantrone—lymphatic system cancer	0.00181	0.00335	CcSEcCtD
Estriol—Pain—Bleomycin—lymphatic system cancer	0.0018	0.00334	CcSEcCtD
Estriol—Headache—Fludarabine—lymphatic system cancer	0.0018	0.00334	CcSEcCtD
Estriol—Anxiety—Mitoxantrone—lymphatic system cancer	0.00178	0.00329	CcSEcCtD
Estriol—Cerebrovascular accident—Methotrexate—lymphatic system cancer	0.00177	0.00328	CcSEcCtD
Estriol—Anaphylactic shock—Vincristine—lymphatic system cancer	0.00175	0.00325	CcSEcCtD
Estriol—Oedema—Vincristine—lymphatic system cancer	0.00175	0.00325	CcSEcCtD
Estriol—Infection—Vincristine—lymphatic system cancer	0.00174	0.00323	CcSEcCtD
Estriol—Nervous system disorder—Vincristine—lymphatic system cancer	0.00172	0.00319	CcSEcCtD
Estriol—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.00171	0.00317	CcSEcCtD
Estriol—Oedema—Mitoxantrone—lymphatic system cancer	0.00171	0.00317	CcSEcCtD
Estriol—Nausea—Fludarabine—lymphatic system cancer	0.00171	0.00316	CcSEcCtD
Estriol—Infection—Mitoxantrone—lymphatic system cancer	0.0017	0.00315	CcSEcCtD
Estriol—Shock—Mitoxantrone—lymphatic system cancer	0.00168	0.00312	CcSEcCtD
Estriol—Urticaria—Bleomycin—lymphatic system cancer	0.00167	0.0031	CcSEcCtD
Estriol—Insomnia—Carmustine—lymphatic system cancer	0.00166	0.00308	CcSEcCtD
Estriol—Skin disorder—Mitoxantrone—lymphatic system cancer	0.00166	0.00308	CcSEcCtD
Estriol—Insomnia—Vincristine—lymphatic system cancer	0.00159	0.00294	CcSEcCtD
Estriol—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.00159	0.00294	CcSEcCtD
Estriol—Pain—Carmustine—lymphatic system cancer	0.00157	0.00291	CcSEcCtD
Estriol—Breast disorder—Methotrexate—lymphatic system cancer	0.00156	0.0029	CcSEcCtD
Estriol—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00155	0.00288	CcSEcCtD
Estriol—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.00151	0.00281	CcSEcCtD
Estriol—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.0015	0.00279	CcSEcCtD
Estriol—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.0015	0.00279	CcSEcCtD
Estriol—Pain—Vincristine—lymphatic system cancer	0.0015	0.00278	CcSEcCtD
Estriol—Asthma—Methotrexate—lymphatic system cancer	0.0015	0.00278	CcSEcCtD
Estriol—Pruritus—Bleomycin—lymphatic system cancer	0.00149	0.00276	CcSEcCtD
Estriol—Pain—Mitoxantrone—lymphatic system cancer	0.00146	0.00271	CcSEcCtD
Estriol—Abdominal pain—Carmustine—lymphatic system cancer	0.00145	0.00269	CcSEcCtD
Estriol—Abdominal discomfort—Methotrexate—lymphatic system cancer	0.00143	0.00266	CcSEcCtD
Estriol—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.00143	0.00266	CcSEcCtD
Estriol—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.0014	0.00259	CcSEcCtD
Estriol—Abdominal pain—Vincristine—lymphatic system cancer	0.00139	0.00257	CcSEcCtD
Estriol—Urticaria—Mitoxantrone—lymphatic system cancer	0.00136	0.00252	CcSEcCtD
Estriol—Hypersensitivity—Carmustine—lymphatic system cancer	0.00135	0.00251	CcSEcCtD
Estriol—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00135	0.0025	CcSEcCtD
Estriol—Vomiting—Bleomycin—lymphatic system cancer	0.00134	0.00248	CcSEcCtD
Estriol—Infestation—Methotrexate—lymphatic system cancer	0.00133	0.00248	CcSEcCtD
Estriol—Infestation NOS—Methotrexate—lymphatic system cancer	0.00133	0.00248	CcSEcCtD
Estriol—Depression—Methotrexate—lymphatic system cancer	0.00133	0.00247	CcSEcCtD
Estriol—Rash—Bleomycin—lymphatic system cancer	0.00133	0.00246	CcSEcCtD
Estriol—Dermatitis—Bleomycin—lymphatic system cancer	0.00133	0.00246	CcSEcCtD
Estriol—Hypersensitivity—Vincristine—lymphatic system cancer	0.00129	0.0024	CcSEcCtD
Estriol—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.00126	0.00234	CcSEcCtD
Estriol—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.00126	0.00233	CcSEcCtD
Estriol—Diarrhoea—Carmustine—lymphatic system cancer	0.00126	0.00233	CcSEcCtD
Estriol—Nausea—Bleomycin—lymphatic system cancer	0.00125	0.00232	CcSEcCtD
Estriol—Dizziness—Carmustine—lymphatic system cancer	0.00122	0.00225	CcSEcCtD
Estriol—Diarrhoea—Vincristine—lymphatic system cancer	0.0012	0.00223	CcSEcCtD
Estriol—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00117	0.00217	CcSEcCtD
Estriol—Vomiting—Carmustine—lymphatic system cancer	0.00117	0.00217	CcSEcCtD
Estriol—Dizziness—Vincristine—lymphatic system cancer	0.00116	0.00215	CcSEcCtD
Estriol—Rash—Carmustine—lymphatic system cancer	0.00116	0.00215	CcSEcCtD
Estriol—Dermatitis—Carmustine—lymphatic system cancer	0.00116	0.00215	CcSEcCtD
Estriol—Visual impairment—Methotrexate—lymphatic system cancer	0.00115	0.00214	CcSEcCtD
Estriol—Headache—Carmustine—lymphatic system cancer	0.00115	0.00214	CcSEcCtD
Estriol—Erythema multiforme—Methotrexate—lymphatic system cancer	0.00113	0.0021	CcSEcCtD
Estriol—Eye disorder—Methotrexate—lymphatic system cancer	0.00112	0.00208	CcSEcCtD
Estriol—Vomiting—Vincristine—lymphatic system cancer	0.00112	0.00207	CcSEcCtD
Estriol—Cardiac disorder—Methotrexate—lymphatic system cancer	0.00111	0.00206	CcSEcCtD
Estriol—Rash—Vincristine—lymphatic system cancer	0.00111	0.00205	CcSEcCtD
Estriol—Dermatitis—Vincristine—lymphatic system cancer	0.00111	0.00205	CcSEcCtD
Estriol—Headache—Vincristine—lymphatic system cancer	0.0011	0.00204	CcSEcCtD
Estriol—Nausea—Carmustine—lymphatic system cancer	0.00109	0.00202	CcSEcCtD
Estriol—Angiopathy—Methotrexate—lymphatic system cancer	0.00109	0.00202	CcSEcCtD
Estriol—Vomiting—Mitoxantrone—lymphatic system cancer	0.00109	0.00201	CcSEcCtD
Estriol—Immune system disorder—Methotrexate—lymphatic system cancer	0.00108	0.00201	CcSEcCtD
Estriol—Rash—Mitoxantrone—lymphatic system cancer	0.00108	0.002	CcSEcCtD
Estriol—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00108	0.002	CcSEcCtD
Estriol—Headache—Mitoxantrone—lymphatic system cancer	0.00107	0.00199	CcSEcCtD
Estriol—Alopecia—Methotrexate—lymphatic system cancer	0.00106	0.00196	CcSEcCtD
Estriol—Mental disorder—Methotrexate—lymphatic system cancer	0.00105	0.00195	CcSEcCtD
Estriol—Malnutrition—Methotrexate—lymphatic system cancer	0.00104	0.00193	CcSEcCtD
Estriol—Nausea—Vincristine—lymphatic system cancer	0.00104	0.00193	CcSEcCtD
Estriol—Nausea—Mitoxantrone—lymphatic system cancer	0.00101	0.00188	CcSEcCtD
Estriol—Back pain—Methotrexate—lymphatic system cancer	0.00101	0.00187	CcSEcCtD
Estriol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000882	0.00164	CcSEcCtD
Estriol—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000851	0.00158	CcSEcCtD
Estriol—Infection—Methotrexate—lymphatic system cancer	0.000846	0.00157	CcSEcCtD
Estriol—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000835	0.00155	CcSEcCtD
Estriol—Skin disorder—Methotrexate—lymphatic system cancer	0.000827	0.00153	CcSEcCtD
Estriol—Insomnia—Methotrexate—lymphatic system cancer	0.00077	0.00143	CcSEcCtD
Estriol—Dyspepsia—Methotrexate—lymphatic system cancer	0.000749	0.00139	CcSEcCtD
Estriol—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000735	0.00136	CcSEcCtD
Estriol—Pain—Methotrexate—lymphatic system cancer	0.000728	0.00135	CcSEcCtD
Estriol—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000696	0.00129	CcSEcCtD
Estriol—Urticaria—Methotrexate—lymphatic system cancer	0.000676	0.00125	CcSEcCtD
Estriol—Abdominal pain—Methotrexate—lymphatic system cancer	0.000673	0.00125	CcSEcCtD
Estriol—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000627	0.00116	CcSEcCtD
Estriol—Pruritus—Methotrexate—lymphatic system cancer	0.000602	0.00112	CcSEcCtD
Estriol—Diarrhoea—Methotrexate—lymphatic system cancer	0.000582	0.00108	CcSEcCtD
Estriol—Dizziness—Methotrexate—lymphatic system cancer	0.000563	0.00104	CcSEcCtD
Estriol—Vomiting—Methotrexate—lymphatic system cancer	0.000541	0.001	CcSEcCtD
Estriol—Rash—Methotrexate—lymphatic system cancer	0.000537	0.000995	CcSEcCtD
Estriol—Dermatitis—Methotrexate—lymphatic system cancer	0.000536	0.000995	CcSEcCtD
Estriol—Headache—Methotrexate—lymphatic system cancer	0.000533	0.000989	CcSEcCtD
Estriol—Nausea—Methotrexate—lymphatic system cancer	0.000506	0.000938	CcSEcCtD
